A more sensitive marker which triggers the immune reaction, i.e., the increased production of IL10 and IFN-γ, and polarization of Th1 and Th2 cells at the same time, will be needed to predict the onset of GVHD in advance. The gene discussed is IFNG; the disease is graft versus host disease.